Skip to main content

Select Drug Profiles

Select Drug Profiles, Payers' Guide

Abraxane Receives New Indication for Locally Advanced or Metastatic Non–Small-Cell Lung Cancer When Curative Surgery or Radiation Therapy Is Not an Option

Lynne Lederman, PhD

Select Drug Profiles, Payers' Guide

Eliquis Approved by the FDA to Reduce the Risks of Stroke and Systemic Embolism in Patients with Atrial Fibrillation

Select Drug Profiles, Payers' Guide

The Health Burden of Multiple Myeloma: Subcutaneous Velcade a New, Convenient Route of Administration Option

Rhonda Williams, Medical Writer

Select Drug Profiles, Payers' Guide

Kyprolis: A New Treatment Option for Patients with Relapsed/Refractory Multiple Myeloma Previously Treated with Bortezomib and an Immunomodulatory Agent

Lynne Lederman, PhD, Medical Writer

Select Drug Profiles, Payers' Guide

Jentadueto: A New Oral Antihyperglycemic Combination Therapy for Patients with Type 2 Diabetes

Wayne Kuznar, Medical Writer

Select Drug Profiles, Payers' Guide

Linzess: A Novel Treatment Option for Constipation Associated with Irritable Bowel Syndrome

Alice Goodman, Medical Writer

Select Drug Profiles, Payers' Guide

Perjeta: A New Option for Patients with HER2-Positive Metastatic Breast Cancer

Alice Goodman, Medical Writer

Select Drug Profiles, Payers' Guide

Iclusig: A New Treatment Option for Adults with CML or Ph+ ALL that Is Resistant/ Intolerant to Previous Therapy with TKIs

Lynne Lederman, PhD, Medical Writer

Select Drug Profiles, Payers' Guide

Qsymia: Combination Oral Therapy a New Weight-Loss Option for Obese or Overweight Patients

Select Drug Profiles, Payers' Guide

Rayos: A Novel Oral Delayed-Release Prednisone for the Treatment of Rheumatoid Arthritis and Other Inflammatory Diseases

Alice Goodman, Medical Writer

1
2
3
4

Page 1 of 20
Results 1 - 10 of 200